• AO/PI Double Staining Kit: Practical Guide for Cell Viabilit

  2026-04-24

  The AO/PI Double Staining Kit enables rapid, simultaneous assessment of cell viability, apoptosis, and necrosis using dual fluorescent dyes. This kit is best suited for researchers requiring clear discrimination among live, apoptotic, and necrotic cells in a single workflow. It is not intended for mechanistic pathway analysis beyond viability and death categorization.

• Licoricidin Inhibits HCC Growth and Metastasis via PI3K/AKT

  2026-04-24

  This study demonstrates that licoricidin, a prenylated isoflavone from licorice, suppresses hepatocellular carcinoma (HCC) proliferation and metastasis by targeting PI3K/AKT signaling. The findings highlight licoricidin's potential as a therapeutic agent and provide mechanistic insights for future drug development.

• TAK-715: Precision p38 MAPK Inhibitor for Inflammation Assay

  2026-04-23

  TAK-715 stands out as a highly selective, nanomolar-potency p38 MAPK inhibitor for dissecting cytokine signaling and inflammation pathways. Its dual-action mechanism and robust anti-inflammatory profile make it the premier choice for reliable, reproducible research in chronic inflammatory disease models.

• Canonical Anti-Apoptotic Role of MCL-1 in Breast Cancer Reve

  2026-04-23

  This article discusses a landmark study establishing that breast cancer's dependence on MCL-1 arises from its canonical anti-apoptotic function. The findings clarify the mechanism of MCL-1 in tumor maintenance and reinforce the rationale for using selective MCL-1 inhibitors in apoptosis-focused cancer research.

• Homoharringtonine: Mechanistic Foundations and Translational

  2026-04-22

  Explore the advanced mechanistic profile of Homoharringtonine, a potent cytotoxic alkaloid, and its breakthrough applications in cancer biology and SARS-CoV-2 antiviral research. This article delivers uniquely deep scientific insight and actionable guidance for translational assay development.

• Bovine Liver Organoid Models Advance Fatty Liver Research in

  2026-04-22

  Lei et al. introduce a bovine liver organoid system that faithfully models fatty liver disease in dairy cows, enabling controlled studies of disease mechanisms and therapeutic interventions. This innovation reduces reliance on animal models and provides a reproducible in vitro platform for screening candidate compounds.

• Minoxidil Sulphate in Vascular & Hair Growth Assays: Applied

  2026-04-21

  Minoxidil sulphate, the active metabolite of minoxidil, empowers researchers to dissect potassium channel mechanisms in both vascular biology and hair growth models. This guide unpacks protocol optimization, troubleshooting, and best practices for maximizing reproducibility and performance with APExBIO’s high-purity Minoxidil sulphate.

• Entinostat (MS-275): Precision HDAC1/3 Inhibition in Cancer

  2026-04-21

  Entinostat (MS-275) enables targeted epigenetic modulation by selectively inhibiting HDAC1 and HDAC3, offering robust anti-proliferative and pro-apoptotic effects. This article guides researchers through nuanced workflows, experimental optimization, and troubleshooting strategies to maximize reliability and translational impact in cancer studies.

• DiscoveryProbe Bioactive Compound Library Plus in Ligand Scr

  2026-04-20

  Leverage the DiscoveryProbe Bioactive Compound Library Plus to accelerate ligand identification and pathway analysis with 5,072 quality-controlled, cell-permeable small molecules. This article details optimized experimental workflows, advanced applications in cancer and immunology research, and actionable troubleshooting tips for maximizing high-throughput screening results.

• RBM28 Modulates p53 Activity via Nucleolar-Nucleoplasmic Shu

  2026-04-20

  This study identifies RBM28 as a nucleolar stress sensor that translocates to the nucleoplasm and suppresses p53 transcriptional activity, supporting cancer cell survival. The findings reveal new mechanistic insights into nucleolar stress responses and highlight RBM28 as a potential therapeutic target in oncology.

• Necrostatin 2 (Nec-2): Precision RIPK2 Inhibition in Transla

  2026-04-19

  This article deconstructs the mechanistic underpinnings and translational potential of Necrostatin 2 (Nec-2) as a potent and selective RIPK2 inhibitor in necroptosis research. Moving beyond standard product overviews, it integrates recent discoveries in membrane lipid dynamics and immune signaling, offering actionable insights for researchers designing next-generation cell death assays, particularly in the context of ischemic stroke and programmed necrotic cell death.

• SAG: Smoothened Receptor Agonist for Advanced Hedgehog Assay

  2026-04-18

  Unlock precise Hedgehog pathway modulation using Smoothened Agonist (SAG), a potent tool for developmental biology, neuroprotection, and teratogenicity modeling. Discover optimized protocols, troubleshooting strategies, and novel insights from recent embryonic development studies.

• Applied Workflows for PKM2 Inhibitor (Compound 3k) in Cancer

  2026-04-17

  PKM2 inhibitor (compound 3k) offers precise disruption of cancer glycolysis and novel immunometabolic modulation. This article details validated protocols, highlights breakthrough findings on macrophage polarization, and delivers troubleshooting guidance to maximize experimental impact.

• E-64: Precision Tool for Dissecting Cathepsin Regulation in

  2026-04-16

  Explore how E-64, an L-trans-epoxysuccinyl peptide, enables advanced mechanistic studies of cysteine protease inhibition in inflammatory signaling. This article uniquely examines E-64’s role in cathepsin modulation and experimental assay design, bridging protease biochemistry with translational research.

• Decoding Cy3 RNA Labeling: HyperScribe™ T7 Kit for Advanced

  2026-04-15

  Explore how the HyperScribe T7 High Yield Cy3 RNA Labeling Kit empowers researchers to engineer robust, tunable fluorescent RNA probes—with advanced protocol guidance and cross-validated insights for next-generation mRNA research.

16085 records 1/1073 page Next 12345 下5页 Last page